Download data on suicides in Massachusetts by demographics and year. This page also includes reporting on military & veteran suicide, and suicides during COVID-19.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. Johnson AG, Linde L, Ali AR, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022. MMWR Morb Mortal Wkly Rep 2023;72:145–152. Johnson AG, Linde L, Payne AB, et al. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023. MMWR Morb Mortal Wkly Rep 2023;72:667–669.

Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.

ABSTRACT Objective To describe the epidemiological profile and analyze the time trend of suicide mortality among adolescents (10-19 years old) from the Brazilian Northeast, from 2001 to 2015. Methods This is an observational study, which took place in the Northeast region, Brazil. The study period was from 2001 to 2015. Deaths from intentional self-harm (X60 to X84). exogenous poisoning of undetermined intent (Y10 to Y19) and intentional self-harm (Y87.0) were considered, according to the 10th Review of the International Classification of Diseases (ICD-10), for adolescents aged 10 to 19 years. The variables analyzed were: sex, age group, race / color, specific ICD, state of residence and suicide mortality rate/100,000 inhabitants. Results There were 3,194 deaths due to suicide in the age group studied, with a male predominance (62.1%; n = 1,984), age group 15 to 19 years (84.8%; n = 2,707), race/brown color (65.4%; n = 2,090); between 4 and 7 years of schooling (31.7%; n = 1,011) and at CID X70 (47.8%; n = 1,528). The time trend of mortality was increasing from 2001 to 2015 (APC: 2.4%; p < 0.01), with higher rates in males. There was an increasing trend in the suicide rate, among men, throughout the period (AAPC: 2.9%; p < 0.01). In women, a decreasing trend was identified as of 2004 (APC: -2.2%; p < 0.01). Conclusion The epidemiological profile was characterized by male gender, age group 15-19 years, color/brown race and average schooling. The trend showed a growth pattern in males and a decline in females. It is recommended that public policies are aimed at the adolescent population.

BackgroundMental health conditions and psychiatric disorders are among the leading causes of illness, disability, and death among young people around the globe. In the United States, teen suicide has increased by about 30% in the last decade. Raising awareness of warning signs and promoting access to mental health resources can help reduce suicide rates for at-risk youth. However, death by suicide remains a taboo topic for public discourse and societal intervention. An unconventional approach to address taboo topics in society is the use of popular media.MethodWe conducted a quantitative content analysis of mainstream news reporting on the controversial Netflix series 13 Reasons Why Season 1. Using a combination of top-down and bottom-up search strategies, our final sample consisted of 97 articles published between March 31 and May 31, 2017, from 16 media outlets in 3,150 sentences. We systematically examined the news framing in these articles in terms of content and valence, the salience of health/social issue related frames, and their compliance with the WHO guidelines.ResultsNearly a third of the content directly addressed issues of our interest: 61.6% was about suicide and 38.4% was about depression, bullying, sexual assault, and other related health/social issues; it was more negative (42.8%) than positive (17.4%). The criticism focused on the risk of suicide contagion, glamorizing teen suicide, and the portrayal of parents and educators as indifferent and incompetent. The praise was about the show raising awareness of real and difficult issues young people struggle with in their everyday life and serving as a conversation starter to spur meaningful discussions. Our evaluation of WHO guideline compliance for reporting on suicide yielded mixed results. Although we found recommended practices across all major categories, they were minimal and could be improved.ConclusionDespite their well intentions and best efforts, the 13 Reasons Why production team missed several critical opportunities to be better prepared and more effective in creating social impact entertainment and fostering difficult dialogs. There is an urgent need to train news reporters about established health communication guidelines and promote best practices in media reporting on sensitive topics such as suicide.

The data shows the statistics of different item-wise reports on a cumulative yearly basis in states up to the sub-district level in Kerala. It included 1) Ante Natal Care (ANC) - Antenatal care (ANC) is a means to identify high-risk pregnancies and educate women so that they might experience healthier delivery and outcomes. 2) Deliveries - The delivery of the baby by the pregnant women 3) Number of Caesarean (C-Section) deliveries - Caesarean delivery (C-section) is used to deliver a baby through surgical incisions made in the abdomen and uterus. 4) Pregnancy outcome & details of new-born - The records kept of the pregnancy outcome along with the details of new-born 5) Complicated Pregnancies - The different pregnancies that were not normal and had complications 6) Post Natal Care (PNC) - Postnatal care is defined as care given to the mother and her new-born baby immediately after the birth of the placenta and for the first six weeks of life 7) Reproductive Tract Infections/Sexually Transmitted Infections (RTI/STI) Cases - The records of reproductive tract infections along with the records of the sexually transmitted cases 8) Family Planning - The different methods used by families to keep track of family 9) CHILD IMMUNISATION - The records of child immunisation which are records of vaccination 10) Number of cases of Childhood Diseases (0-5 years) - The records of the number of cases of childhood diseases within the age of 5 years old 11) NVBDCP - The National Vector Borne Disease Control Programme (NVBDCP) is one of the most comprehensive and multi-faceted public health activities in the country and concerned with the prevention and control of vector-borne diseases, namely Malaria, Filariasis, Kala-azar, Dengue and Japanese Encephalitis (JE). 12) Adolescent Health - The record of the conditions of adolescent health 13 ) Directly Observed Treatment, Short-course (DOTS) - Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to tuberculosis (TB) control strategy recommended by the World Health Organization 14) Patient Services - Patient Services means those which vary with the number of personnel; professional and para-professional skills of the personnel; specialised equipment, and reflect the intensity of the medical and psycho-social needs of the patients. 15) Laboratory Testing - A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Laboratory tests can help determine a diagnosis, plan treatment, check if the treatment works, or monitor the disease over time. 16) Details of deaths reported with probable causes - The reports of deaths recorded with possible reasons are given in a detail 17) Vaccines - The reports of vaccines which are recorded 18) Syringes - It is the number of syringes that are used and recorded 19) Rashtriya Bal Swasthaya Karyakram (RBSK) - Rashtriya Bal Swasthya Karyakram (RBSK) is an important initiative aiming at early identification and early intervention for children from birth to 18 years to cover 4 'D's viz. Defects at birth, Deficiencies, Diseases, Development delays, including disability. 20) Coverage under WIFS JUNIOR - The coverage of the Weekly Iron Folic Acid Supplementation Programme for children six to one 21) Maternal Death Reviews (MDR) - A maternal death review cross-checks how the mother died. It provides a rare opportunity for a group of health staff and community members to learn from a tragic – and often preventable. 22) Janani Shishu Suraksha Karyakaram (JSSK)- This initiative provides free and cashless services to pregnant women, including standard deliveries and caesarean operations. It entitles all pregnant women in public health institutions to free and no-expense delivery, including caesarean section.